Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
PowerCompute, a Nasdaq-listed Bitcoin treasury and mining company expanding into high-performance computing (HPC) and artificial intelligence (AI) infrastructure, will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The company highlighted its Verified status on the Vast.ai compute marketplace and recent acquisition of …
Shattuck Labs, a clinical-stage biotech company focused on developing monoclonal and bispecific DR3 blocking antibodies for inflammatory and immune diseases, announced that management will participate in the Wells Fargo 21st Annual Healthcare Conference and the Cantor Global Healthcare Conference in September 2026. The presentations will include fi…
SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary AlloyX HK has signed a strategic non-binding MOU with EvolveQ to explore the integration of AI, quantum computing, and high-performance computing in finance and digital assets. The collaboration aims to develop next-generation AI wealth management platforms, enhance AI infrastructure, and…
Attovia Therapeutics announced second quarter 2026 financial results alongside positive clinical updates for its lead product ATTO-1310 in treating chronic pruritus and atopic dermatitis. The company plans Phase 2 studies for 2027 and has strengthened its cash runway into 2030 following an upsized IPO raising $332.4 million. Additional pipeline can…
Robinhood Markets, Inc. announced that CEO Vlad Tenev will present at the upcoming Goldman Sachs Communacopia + Technology Conference. The presentation will be webcast live and available for replay, providing investors insights into company developments and strategy.
Superior Group of Companies, Inc. announced that its CEO Michael Benstock and President/CFO Mike Koempel will participate in the Northcoast Research and Sidoti virtual conferences in September 2026, including investor meetings and a fireside chat. The company highlighted its diversified business segments and strategy focused on organic growth and a…
Surrozen, Inc., a Nasdaq-listed biotechnology company focused on Wnt signaling therapeutics for sight-threatening ophthalmic diseases, announced that its management will present at the 2026 Cantor Global Healthcare and Morgan Stanley Global Healthcare conferences. The company provided updates on its development plans including initiating a Phase 1b…
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that its CEO and CFO will present at the Morgan Stanley Global Healthcare Conference and Deutsche Bank Healthcare Summit in September 2026. The company aims to share its business outlook and strategies with investors during these…
Matrix Service Company announced Q4 fiscal 2026 revenue growth to $244.5 million, the highest quarterly revenue in six years, with a net income of $1.1 million compared to a loss in the prior year. The company achieved adjusted net income for the second consecutive profitable quarter and ended the fiscal year with liquidity of $283.9 million and no…
Five Below, Inc. delivered solid financial results for Q2 FY 2026, with net sales increasing 22.9% to $1.26 billion and comparable sales up 14.1%. Operating income surged significantly, and diluted EPS increased to $3.99 from $0.77 year-over-year. The company opened 52 net new stores this quarter, totaling 2,022 stores nationwide. With strong momen…
Ultragenyx Pharmaceutical announced that its Phase 3 Aspire clinical trial of apazunersen (GTX-102) for Angelman syndrome did not meet the primary or key secondary efficacy endpoints. Despite a consistent safety profile, the company expressed disappointment and will evaluate the future of the program while planning to implement significant expense …
Oxford Lane Capital Corp., a closed-end management investment company focusing on CLO debt and equity tranches, announced it will redeem $30 million aggregate principal amount of its 5.00% Notes due 2027 at $25 per Note plus accrued interest, with redemption effective October 2, 2026. The Notes trade on Nasdaq under ticker OXLCZ.
Spero Therapeutics, a clinical-stage biopharmaceutical company specializing in immunology and inflammation, announced that its CEO, Esther Rajavelu, will present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company’s pipeline with a focus on its lead program, SP001, targeting immune-media…
Duolingo announced that CEO Luis von Ahn will participate in a fireside chat at the Citi 2026 Global TMT Conference. The event will be webcast live and later available for replay. Duolingo is recognized as the leading mobile language learning platform globally, known for its highly popular app and commitment to quality and accessibility in educatio…
Black Diamond Therapeutics announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference, with a presentation and one-on-one investor meetings scheduled. The company highlighted advancements in its investigational EGFR inhibitor, silevertinib, targeting oncology indications such as EGFR-mutant non-small cell lung cance…
Aura Biosciences, a clinical-stage biotechnology company focused on developing a novel therapy for ocular cancers, announced its CEO, Natalie Holles, will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. The company highlighted its Phase 3 fully enrolled trial for bel-sar in early choroidal melanoma and ongoing studies in…
Kymera Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation for immunological diseases, announced its participation in several upcoming investor conferences throughout September 2026. The company will present and participate in fireside chats at major events hosted by Wells Fargo, Citi, H.C. Wainwrig…
Arcutis Biotherapeutics, a commercial-stage biopharmaceutical company focusing on immuno-dermatology, announced that its management will present at the Morgan Stanley 24th Annual Global Healthcare Conference in September 2026. The presentation will provide insights into the company's progress and strategies. The company also reaffirmed its commitme…
Cytokinetics, a specialty cardiovascular biopharmaceutical company, announced that members of its management team will participate in multiple investor conferences in September 2026, including Citi, Cantor, Morgan Stanley, and Bernstein events. The company will discuss progress on its cardiac myosin inhibitors and activators, including the approved…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company focused on CNS diseases, announced that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its outstanding Form 10-Q reports for the second and third quarters of 2026. Consequently, its common stock will continue trading on the Nasdaq Global Select Marke…
Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company focused on novel Alzheimer's therapeutics, will participate in upcoming investor conferences to discuss progress and developments. The company is advancing its lead drug candidate, sabirnetug, in Phase 2 trials and exploring innovative delivery technologies.
U.S. crude oil production rose modestly in June to 13.79 million barrels per day from 13.76 million in May, while demand for crude and petroleum products increased to 20.74 million barrels per day. Natural gas production also climbed to 135.5 billion cubic feet per day, with Texas recording a new monthly high of 39.2 billion cubic feet per day, acc…
AMD is positioned to take a larger share of the AI compute market thanks to competitive server CPUs and accelerating GPU/accelerator momentum. This trade plan lays out an entry at $140.00 with a $190.00 target and a $120.00 stop, sized for a medium-risk, long-term horizon of 180 trading days.
Netlist Inc. shares fell sharply in afternoon trading after the U.S. Court of Appeals for the Federal Circuit affirmed a Patent Trial and Appeal Board finding that all challenged claims of one of the company's key memory patents are unpatentable as obvious. The court found Netlist's arguments "not persuasive," delivering a victory to Micron Technol…
Toll Brothers, a leading luxury homebuilder, has opened a new model home at their master-planned community, The Crossing at Coal Mountain in Cumming, GA. The Oakridge Elite with Loft, part of the Haven Collection, showcases spacious, modern design with upscale features and is priced from the low $500,000s. This launch highlights Toll Brothers' comm…
